Results 21 to 30 of about 239,525 (205)

Meningococcal Vaccinations [PDF]

Infectious Diseases and Therapy, 2016
Neisseria meningitidis, a gram-negative diplococcal bacterium, is a common asymptomatic nasopharyngeal colonizer that may infrequently lead to invasive disease in the form of meningitis or bacteremia. Six serogroups (A, B, C, W, X and Y) are responsible for the majority of invasive infections.
Crum-Cianflone, Nancy, Sullivan, Eva
openaire   +2 more sources

Promising pharmaceutical development of vaccines for the prevention of meningococcal infection

Журнал микробиологии, эпидемиологии и иммунобиологии, 2023
Meningococcal infection (MI) refers to anthroponoses; is an acute infectious disease with an aerosol transmission mechanism, characterized by various forms of the infectious process: from local (nasopharyngitis) and asymptomatic infections to generalized
Maria V. Savkina, Lidiya V. Sayapina, Maxim A. Krivykh, Yury I. Obukhov   +3 more
doaj   +1 more source

Meningococcal vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2012
Meningococcal meningitis is caused by Neisseria meningitidis, a gram-negative, aerobic, encapsulated diplococcus. Meningococci are divided into numerous serogroups based on the composition of their capsular polysaccharide (Ps) antigens. At least 13 serogroups have been described: A, B, C, D, 29E, H, I, K, L, W-135, X, Y and Z.
Ramesh, Verma, Pardeep, Khanna
openaire   +2 more sources

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland

mSphere, 2018
Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity ...
Robert M. Mulhall, Desiree Bennett, Robert Cunney, Ray Borrow, Jay Lucidarme, Jamie Findlow, Keith A. Jolley, James Bray, Martin C. J. Maiden, Monica Moschioni, Laura Serino, Maria Stella, Duccio Medini   +12 more
doaj   +1 more source

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation [PDF]

, 2011
Natural fluctuations in carried meningococcal genotypes and phenotypes a can be affected by the use of conjugate vaccines, and not all of these changes are anticipatable in advance of vaccine ...
McCarthy, Noel D., Maclennan, Jenny, Evans, Meirion R, Rachel Urwin, Cameron, J. Claire, Neal, Keith R, Nicholas J. Andrews, Stuart C. Clarke, Cann, Kathryn, Noel D. McCarthy, Cameron, JC, Evans, MR, James M. Stuart, Harrison, S, Ala'aldeen, Dlawer, Cunningham, Richard, Martin C. J. Maiden, Jolley, Keith A, Derrick W. Crook, Dlawer Ala'Aldeen, Walker, AM, Baxter, David, Gray, Stephen J., Urwin, R, Crook, Derrick W., Keith R. Neal, Clarke, SC, Clarke, Stuart C, Maiden, Martin C. J., Jolley, Keith A., Stuart, James M., Maiden, Martin CJ, Keith A. Jolley, Kaczmarski, E, Walker, A. Mark, J. Simon Kroll, Richard Cunningham, Andrews, NJ, J. Claire Cameron, Crook, DW, Evans, Meirion Rhys, Harrison, Sarah, Andrews, Nicholas J, Edward Kaczmarski, Baxter, D, McCarthy, Noel D, Cann, K, Crook, Derrick W, Kathryn Cann, Ibarz-Pavón, Ana Belén, Clarke, Stuart C., Evans, Meirion R., A. Mark Walker, Cunningham, R, Kroll, J. Simon, Kroll, J Simon, Neal, KR, Cameron, J Claire, Maiden, MCJ, Andrews, Nicholas J., Neal, Keith R., McCarthy, ND, Stephen J. Gray, Jenny MacLennan, Meirion R. Evans, Urwin, Rachel, Stuart, James M, Stuart, JM, Sarah Harrison, Gray, SJ, Gray, Stephen J, Ana Belén Ibarz-Pavón, Walker, A Mark, Kaczmarski, Edward, David Baxter, Kroll, JS, Jolley, KA, Ala'Aldeen, D, MacLennan, J, Ibarz-Pavon, AB   +79 more
core   +1 more source

Changes in Post-Transplant Vaccine Coverage After Implementing Structured Vaccine Reviews in Pediatric Solid Organ Transplant Recipients in British Columbia, Canada: A Canadian Immunization Research Network Study. [PDF]

Pediatr Transplant
Structured annual infectious diseases specialist‐led vaccine reviews, including individualized recommendations, standardized checklists, and facilitated vaccine access, integrated into routine post‐transplant care, significantly improved vaccine coverage in pediatric solid organ transplant recipients.
Barbey FA, Sadarangani M, Burton C, Urschel S, MacDonald SE, McConnell A, Morin E, Meesters K, Blydt-Hansen T, Yong E, Mitchell H, Special Immunization Clinic Network Investigators.   +11 more
europepmc   +2 more sources

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age

Human Vaccines & Immunotherapeutics, 2022
Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs) against IMD, meningococcal conjugate vaccines have contributed to significant declines in incidence ...
Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson, Philipp Oster   +3 more
doaj   +1 more source

Review of meningococcal vaccines with updates on immunization in adults [PDF]

, 2014
Meningococcal disease is a serious and global life-threatening disease. Six serogroups (A, B, C, W-135, X, and Y) account for the majority of meningococcal disease worldwide.
Dbaibo, Ghassan S., Ghanem, Soha T., Zahlanie, Yorgo C., Hammadi, Moza M., Dbaibo G.S., Zahlanie Y.C., Hammadi M.M., Ghanem S.T.   +7 more
core   +1 more source

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review

Infectious Diseases and Therapy, 2019
Neisseria meningitidis is a major cause of meningitis and septicemia with cases, outbreaks, and epidemics reported globally in industrialized and non-industrialized countries. N. meningitidis is categorized into 12 serogroups; however, only 5 serogroups (
Jessica Presa, Jamie Findlow, Jelena Vojicic, Scott Williams, Lidia Serra   +4 more
doaj   +1 more source

Meningococcal and pneumococcal meningitis in Northern Ghana [PDF]

, 2008
Despite improvements in technology, treatments and understanding of how bacterial meningitis develops, the disease remains a potentially life-threatening emergency capable of causing significant morbidity and mortality. N. meningitidis, S.
Forgor, Abdulai Adams
core   +1 more source